Browsing Tag
Hetlioz
2 posts
Vanda Pharmaceuticals VQW-765 fails Phase 3 anxiety trial as stock faces fresh pressure
Vanda Pharmaceuticals has paused development of VQW-765 after a 546-patient Phase 3 study failed to demonstrate a significant reduction in social anxiety symptoms. The setback removes a near-term clinical catalyst, placing greater importance on its commercial product launches, cash position and remaining regulatory milestones.
Vanda Pharmaceuticals (VNDA) wins FDA’s first formal drug approval hearing in 40 years as Hetlioz jet lag battle enters new phase
FDA grants Vanda Pharmaceuticals a rare Part 12 public hearing on Hetlioz jet lag rejection, the first such drug approval hearing in 40 years. Read the full analysis.